CA2524368A1 - Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide - Google Patents

Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide Download PDF

Info

Publication number
CA2524368A1
CA2524368A1 CA002524368A CA2524368A CA2524368A1 CA 2524368 A1 CA2524368 A1 CA 2524368A1 CA 002524368 A CA002524368 A CA 002524368A CA 2524368 A CA2524368 A CA 2524368A CA 2524368 A1 CA2524368 A1 CA 2524368A1
Authority
CA
Canada
Prior art keywords
polymer
composition
drug
polysaccharide
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002524368A
Other languages
English (en)
French (fr)
Inventor
Carmen Popescu
Hayat Onyuksel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois System
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2524368A1 publication Critical patent/CA2524368A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002524368A 2003-05-02 2004-04-26 Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide Abandoned CA2524368A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46740003P 2003-05-02 2003-05-02
US60/467,400 2003-05-02
PCT/US2004/012755 WO2004098564A2 (en) 2003-05-02 2004-04-26 Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide

Publications (1)

Publication Number Publication Date
CA2524368A1 true CA2524368A1 (en) 2004-11-18

Family

ID=33435069

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002524368A Abandoned CA2524368A1 (en) 2003-05-02 2004-04-26 Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide

Country Status (5)

Country Link
US (2) US20040247683A1 (enExample)
EP (1) EP1620078A2 (enExample)
JP (1) JP2006525333A (enExample)
CA (1) CA2524368A1 (enExample)
WO (1) WO2004098564A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
WO2005027873A2 (en) * 2003-06-20 2005-03-31 Alnis Biosciences, Inc. Therapeutic aminoglycoside-containing hydrogel nanoparticles
US8628690B2 (en) * 2004-02-23 2014-01-14 The Texas A&M University System Nanoemulsion compositions and methods of use thereof
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
US9119782B2 (en) 2006-03-20 2015-09-01 Mary P. McCourt Drug delivery means
US20090061006A1 (en) * 2006-03-31 2009-03-05 Carola Leuschner Layered Nanoparticles for Sustained Release of Small Molecules
WO2007149868A2 (en) * 2006-06-20 2007-12-27 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
US20080102127A1 (en) * 2006-10-26 2008-05-01 Gao Hai Y Hybrid lipid-polymer nanoparticulate delivery composition
CA2729582C (en) * 2008-07-01 2017-09-19 University Of Chicago Particles containing an opioid receptor antagonist and methods of use
JP6343147B2 (ja) 2010-08-30 2018-06-13 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 狭窄病変および血栓溶解療法のための剪断による制御放出
US9161962B2 (en) * 2010-11-01 2015-10-20 Nanoderm Sciences, Inc. Targeted therapeutic nanoparticles
US20180028684A1 (en) 2010-11-01 2018-02-01 Nanoderm Sciences, Inc. Targeted nanoparticles
WO2012059936A1 (en) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Pharmaceutical compositions for colloidal drug delivery
JP6035633B2 (ja) 2010-12-02 2016-11-30 グリーンマーク バイオメディカル インコーポレイテッドＧｒｅｅｎＭａｒｋ Ｂｉｏｍｅｄｉｃａｌ， Ｉｎｃ． アプタマーバイオコンジュゲート薬物送達システム
CN105164143B (zh) 2013-03-14 2019-02-19 杰罗米.J.申塔格 用于将分子引入到乳糜微粒中的胆固醇体囊泡
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
CA3004363A1 (en) 2015-11-06 2017-05-11 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same
CN105664259B (zh) * 2016-01-18 2018-09-14 铜仁学院 医用钛合金植入物表面药物缓释系统的构建方法
CN106596922B (zh) * 2016-12-06 2018-06-15 湖南大学 用于检测卡那霉素的检测试剂及其制备方法和应用
CA3090303A1 (en) 2018-03-28 2019-10-03 Greenmark Biomedical Inc. Phosphate crosslinked starch nanoparticle and dental treatments
KR20230088732A (ko) 2020-09-29 2023-06-20 옥스포드 유니버시티 이노베이션 리미티드 뇌졸중 치료
CN113069554B (zh) * 2021-04-13 2022-10-21 河南中医药大学 一种齐墩果酸季铵盐-肝素-壳聚糖纳米粒的制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2594374A (en) * 1949-10-11 1952-04-29 Usa Streptomycin-polymyxin-bacitracin composition
FR2631826B1 (fr) * 1988-05-27 1992-06-19 Centre Nat Rech Scient Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation
CA2084194C (en) * 1991-04-02 2003-05-20 Gregory John Russell-Jones Oral delivery systems for microparticles

Also Published As

Publication number Publication date
WO2004098564A2 (en) 2004-11-18
EP1620078A2 (en) 2006-02-01
US20040247683A1 (en) 2004-12-09
JP2006525333A (ja) 2006-11-09
US20080241257A1 (en) 2008-10-02
WO2004098564A3 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
US20080241257A1 (en) Biodegradable Nanoparticles Incorporating Highly Hydrophilic Positively Charged Drugs
US7544374B2 (en) Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
Chae et al. Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis
US9149441B2 (en) Nanospheres encapsulating bioactive material and method for formulation of nanospheres
EP2508207B1 (en) Nanoparticles loaded with chemotherapeutic antitumoral Drug
CN109771663B (zh) 一种酸响应性抗癌纳米药物的制备及应用
CN106729737A (zh) 一种“脱壳”式智能纳米药物复合物及其制备方法
CN108495619A (zh) 棘霉素制剂及其制备方法和使用方法
CN105012271A (zh) 一种共担载阿霉素和trail的白蛋白纳米粒靶向制剂及制备方法
US20240058416A1 (en) Process and composition matter of nanoparticle formulation for systemic treatment of sepsis
US20120171261A1 (en) Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy
CN101888845B (zh) 结合到生物可降解的纳米粒子的金属络合物及其应用
US20090170804A1 (en) Pirfenidone/toll-like receptor (tlr) agonist compositions and methods for using them to stimulate production of granulocyte colonizing stimulating factor (g-csf)
Ahmed et al. Strategies adopted to improve bioavailability of Glibenclamide: Insights on novel delivery systems
CN114288265A (zh) 一种包含顺铂-亚油酸和sn38-亚油酸的纳米颗粒、制备方法及应用
CN110882218A (zh) 脂质体组合物及其制备与应用
Jeetah et al. Dual encapsulation and controlled delivery of anti-TB drugs from PEG-block-poly (ester-ether) nanomicelles
CN117618531B (zh) 抗菌药物组合物、被界面膜包围的胶体颗粒、其制备方法和应用
Bhatia et al. A review on the drug delivery strategies for parasitic infections: scope and assertion
Kadhim et al. Cytotoxicity of sericin nanoparticles loaded with paclitaxel as a pulmonary drug delivery system: in vitro and in vivo studies
Aditi et al. Nano particles as drug delivery agents for antitubercular drugs
Alastal et al. Research Article Enhancing Intranasal Delivery and Bioavailability of Dihydroergotamine Utilizing Chitosan Nanoparticles
CN107550887B (zh) 一种治疗t细胞急性淋巴细胞白血病的复方纳米制剂及制备方法和应用
CN120643511A (zh) 一种双载药阳离子混合胶束及其制备方法和应用
CN116440116A (zh) 一种具有抗菌功能的纳米药物及其应用

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued